Elevance Health (NYSE:ELV) Share Price Crosses Below 50-Day Moving Average – Here’s What Happened

Elevance Health, Inc. (NYSE:ELV – Get Free Report)’s share price passed below its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $416.91 and traded as low as $400.12. Elevance Health shares last traded at $401.3980, with a volume of 1,907,972 shares.

Analyst Upgrades and Downgrades

ELV has been the topic of several recent research reports. Morgan Stanley upped their target price on shares of Elevance Health from $404.00 to $449.00 and gave the company an “equal weight” rating in a research report on Thursday, October 22nd. Wells Fargo & Company lifted their price target on Elevance Health from $473.00 to $492.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 27th. Weiss Ratings reissued a “hold (c)” rating on shares of Elevance Health in a research note on Wednesday, November 11th. TD Cowen boosted their price objective on Elevance Health from $465.00 to $495.00 and gave the stock a “buy” rating in a research note on Friday, October 23rd. Finally, Royal Bank Of Canada upped their price objective on Elevance Health from $424.00 to $455.00 and gave the company a “sector perform” rating in a research report on Thursday, October 22nd. Sixteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $458.91.

Get Our Latest Stock Analysis on Elevance Health

Elevance Health Price Performance

The company has a debt-to-equity ratio of 0.68, a current ratio of 1.47 and a quick ratio of 1.47. The firm has a market cap of $86.73 billion, a P/E ratio of 17.12, a PEG ratio of 2.07 and a beta of 0.63. The stock’s 50-day simple moving average is $416.91 and its two-hundred day simple moving average is $376.44.

Elevance Health (NYSE:ELV – Get Free Report) last announced its earnings results on Wednesday, October 21st. The company reported $6.99 earnings per share for the quarter, beating the consensus estimate of $4.71 by $2.28. The business had revenue of $50.44 billion for the quarter, compared to the consensus estimate of $49.28 billion. Elevance Health had a net margin of 2.55% and a return on equity of 14.97%. The business’s revenue for the quarter was up .7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.03 earnings per share. Equities research analysts forecast that Elevance Health, Inc. will post 29.15 earnings per share for the current fiscal year.

Elevance Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, December 4th will be given a $1.72 dividend. This represents a $6.88 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend is Friday, December 4th. Elevance Health’s dividend payout ratio is 29.34%.

Insider Activity

In other Elevance Health news, EVP Ratnakar Lavu sold 1,300 shares of the business’s stock in a transaction that occurred on Thursday, November 5th. The stock was sold at an average price of $440.00, for a total transaction of $572,000.00. Following the completion of the transaction, the executive vice president owned 14,849 shares in the company, valued at $6,533,560. The trade was a 8.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Mark Kaye sold 10,584 shares of the company’s stock in a transaction that occurred on Thursday, October 22nd. The shares were sold at an average price of $440.13, for a total value of $4,658,335.92. Following the transaction, the chief financial officer directly owned 19,919 shares in the company, valued at approximately $8,766,949.47. This represents a 34.70% decrease in their position. The SEC filing for this sale provides additional information. 0.34% of the stock is owned by company insiders.

Institutional Investors Weigh In On Elevance Health

Institutional investors and hedge funds have recently modified their holdings of the business. Activest Wealth Management increased its stake in Elevance Health by 146.2% in the third quarter. Activest Wealth Management now owns 64 shares of the company’s stock worth $25,000 after purchasing an additional 38 shares during the period. Clal Insurance Enterprises Holdings Ltd bought a new stake in shares of Elevance Health during the third quarter worth $26,000. WealthCollab LLC boosted its stake in shares of Elevance Health by 42.2% during the first quarter. WealthCollab LLC now owns 91 shares of the company’s stock valued at $27,000 after purchasing an additional 27 shares during the period. Kilter Group LLC purchased a new stake in shares of Elevance Health during the second quarter valued at $28,000. Finally, Elevation Wealth Partners LLC grew its holdings in shares of Elevance Health by 600.0% in the second quarter. Elevation Wealth Partners LLC now owns 105 shares of the company’s stock worth $41,000 after purchasing an additional 90 shares during the last quarter. 89.24% of the stock is owned by institutional investors.

Elevance Health Company Profile

(Get Free Report)

Elevance Health, Inc. is a U.S. health benefits and services company. Formerly known as Anthem, Inc., it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans. The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business.

Featured Articles

Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.